Group survival
Donnelly, G.
Nursing Times 74(6): 252-253
1978
ISSN/ISBN: 0954-7762 PMID: 643679 Document Number: 137006
Document emailed within 1 workday
Related Documents
Glik, D.; Gordon, A.; Ward, W.; Kouame, K.; Guessan, M. 1987: Focus group methods for formative research in child survival: an ivoirian example International Quarterly of Community Health Education 8(4): 297-316Noon, M.A.; Hess, C.E. 1976: Acute leukemia in adults: comparison of survival between a treated and an untreated group Southern Medical Journal 69(9): 1157-1160
Magnani, C.; Pastore, G. 1997: Survival of childhood cancer patients in Italy, 1978-1989. ITACARE Working Group Tumori 83(1): 426-489
Black, R.J.; Clarke, J.A.; Warner, J.M. 1991: Malignant melanoma in Scotland: trends in incidence and survival, 1968-87. A review prepared by the CSA Information and Statistics Division for the Health Monitoring Group Health Bulletin 49(1): 97-105
Murphy, S.; Peterson, P.; Iland, H.; Laszlo, J. 1997: Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment Seminars in Hematology 34(1): 29-39
Brandt, C.M.; Wees-Ponchon, A.; Nisand, G.; Verdun, A.; Jobard, P.; Attali, P.; Bousquet, P.; Fincker, J.L. 1994: Survival in acute myocardial infarction in a group of 369 patients consecutively admitted between 1988 and 1992. Analysis of risk factors and medical procedure Archives des Maladies du Coeur et des Vaisseaux 87(7): 861-868
McNaghten, A.D.; Hanson, D.L.; Jones, J.L.; Dworkin, M.S.; Ward, J.W. 1999: Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis. Adult/Adolescent Spectrum of Disease Group Aids 13(13): 1687-1695
Strother, D.; van Hoff, J.; Rao, P.V.; Smith, E.I.; Shamberger, R.C.; Halperin, E.C.; Murray, K.J.; Castleberry, R.P. 1997: Event-free survival of children with biologically favourable neuroblastoma based on the degree of initial tumour resection: results from the Pediatric Oncology Group European Journal of Cancer 33(12): 2121-2125
Tsuchimoto, S.; Kusumoto, K.; Nakajima, Y.; Kakita, A.; Uchino, J.; Natori, T.; Aizawa, M. 1988: Orthotopic liver transplantation in the rat--The effect of blood group (RT2) matching on the survival of liver allografts Nihon Geka Gakkai Zasshi 89(3): 471
Roach, M.; Cirrincione, C.; Budman, D.; Hayes, D.; Berry, D.; Younger, J.; Hart, R.; Henderson, I.C. 1997: Race and survival from breast cancer: based on Cancer and Leukemia Group B trial 8541 Cancer Journal from Scientific American 3(2): 107-112
Gnanasekar, M.; Thirugnanam, S.; Ramaswamy, K. 2009: Short hairpin RNA (shRNA) constructs targeting high mobility group box-1 (HMGB1) expression leads to inhibition of prostate cancer cell survival and apoptosis International Journal of Oncology 34(2): 425-431
Bergholm, U.; Adami, H.O.; Bergström, R.; Bäckdahl, M.; Akerström, G. 1990: Long-term survival in sporadic and familial medullary thyroid carcinoma with special reference to clinical characteristics as prognostic factors. The Swedish MTC Study Group Acta Chirurgica Scandinavica 156(1): 37-46
Jensen, N.E.; Andersen, B.L.; Buhl, G. 1979: Streptococcus group B. a study of the occurrence of Group B streptococci in venereological and gynecological patients and in a control group Ugeskrift for Laeger 141(15): 992-994
Röttinger, E.M. 1995: Survival of children with primitive neuroectodermal tumors and malignant ependymomas of the central nervous system after treatment with 8 cytostatic agents in one day. A report of the Children's Cancer Group Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 171(5): 303-304
Michon, J.; Négrier, S.; Coze, C.; Mathiot, C.; Frappaz, D.; Oskam, R.; Pacquement, H.; Quintana, E.; Bouffet, E.; Bernard, J.L. 1994: Administration of high-dose recombinant interleukin 2 after autologous bone marrow transplantation in patients with neuroblastoma: toxicity, efficacy and survival. a Lyon-Marseille-Curie-east of France Group Study Progress in Clinical and Biological Research 385: 293-300
1997: Association between blood transfusion and survival in a randomised multicentre trial of perioperative adjuvant portal chemotherapy in patients with colorectal cancer. The Swiss Group for Clinical Cancer Research (SAKK) European Journal of Surgery 163(9): 693-701
Reisman, Y.; van Dam, G.M.; Gips, C.H.; Lavelle, S.M.; Euricterus, P.M. 1997: Survival probabilities of Pugh-Child-PBC classified patients in the euricterus primary biliary cirrhosis population, based on the Mayo clinic prognostic model. Euricterus Project Management Group Hepato-Gastroenterology 44(16): 982-989
Ansquer, Y.; Gautier, C.; Fourquet, A.; Asselain, B.; Stoppa-Lyonnet, D. 1998: Survival in early-onset BRCA1 breast-cancer patients. Institut Curie Breast Cancer Group Lancet 352(9127): 541
Nakano, H.; Namatame, K.; Nemoto, H.; Motohashi, H.; Nishiyama, K.; Kumada, K. 1999: A multi-institutional prospective study of lentinan in advanced gastric cancer patients with unresectable and recurrent diseases: effect on prolongation of survival and improvement of quality of life. Kanagawa Lentinan Research Group Hepato-Gastroenterology 46(28): 2662-2668
Ichihashi, H.; Yamauchi, M.; Watanabe, T.; Takagi, H.; Kondo, T. 1988: Prospective adjuvant chemotherapy of mitomycin C plus HCFU for colorectal cancer (2d report)--6-year survival after surgery: Tokai Cooperative Study Group of Surgical Adjuvant Chemotherapy Gan no Rinsho. Japan Journal of Cancer Clinics 34(4): 451-456